MXPA03005372A - Androgenos 14 (15) -insaturados, 15- y/o 16-sustituidos, con perfil de actividad mixto androgenico-progestacional. - Google Patents

Androgenos 14 (15) -insaturados, 15- y/o 16-sustituidos, con perfil de actividad mixto androgenico-progestacional.

Info

Publication number
MXPA03005372A
MXPA03005372A MXPA03005372A MXPA03005372A MXPA03005372A MX PA03005372 A MXPA03005372 A MX PA03005372A MX PA03005372 A MXPA03005372 A MX PA03005372A MX PA03005372 A MXPA03005372 A MX PA03005372A MX PA03005372 A MXPA03005372 A MX PA03005372A
Authority
MX
Mexico
Prior art keywords
profile
progestational
unsaturated
androgen
mixed
Prior art date
Application number
MXPA03005372A
Other languages
English (en)
Inventor
Leysen Dirk
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of MXPA03005372A publication Critical patent/MXPA03005372A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Se describen esteroides relacionados con androgeno, que tienen una doble ligadura ?14 y que llevan un sustituyente en cualquiera de los atomos de carbono numeros 15 y 16, o en ambos. Los esteroides de la presente estan caracterizados porque poseen un perfil mixto de actividades androgenicas y progestagenicas. Esto hace que estos compuestos sean adecuados para terapia de reemplazo hormonal masculino o femenino, asi como para anticoncepcion masculina.
MXPA03005372A 2000-12-15 2001-12-10 Androgenos 14 (15) -insaturados, 15- y/o 16-sustituidos, con perfil de actividad mixto androgenico-progestacional. MXPA03005372A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00204543 2000-12-15
PCT/EP2001/014776 WO2002048169A1 (en) 2000-12-15 2001-12-10 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational profile

Publications (1)

Publication Number Publication Date
MXPA03005372A true MXPA03005372A (es) 2004-04-20

Family

ID=8172438

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005372A MXPA03005372A (es) 2000-12-15 2001-12-10 Androgenos 14 (15) -insaturados, 15- y/o 16-sustituidos, con perfil de actividad mixto androgenico-progestacional.

Country Status (12)

Country Link
US (1) US20040059140A1 (es)
EP (1) EP1343804A1 (es)
JP (1) JP2004520300A (es)
CN (1) CN1481388A (es)
AR (1) AR034194A1 (es)
AU (1) AU2002229663A1 (es)
BR (1) BR0116127A (es)
CA (1) CA2431328A1 (es)
IL (1) IL156208A0 (es)
MX (1) MXPA03005372A (es)
PE (1) PE20020752A1 (es)
WO (1) WO2002048169A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
TW200745156A (en) * 2005-06-17 2007-12-16 Organon Nv Steroids having a mixed androgenic and progestagenic profile
CN110294782B (zh) * 2018-03-22 2023-06-23 天津药业研究院股份有限公司 一种11烯甾体化合物的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3042689A (en) * 1960-11-21 1962-07-03 Searle & Co 16-hydrocarbon substituted 16,17-dihydroxyestren-3-ones, their esters and ethers, and intermediates for their production
US3577410A (en) * 1968-07-30 1971-05-04 American Home Prod 13beta-alkyl-17-hydroxygona-4,14-dien-3-ones
ZA712312B (en) * 1970-04-28 1972-01-26 Ochsner Med Found Alton 4,14-estradiene compounds
US3766224A (en) * 1971-06-03 1973-10-16 Sandoz Ag 15-methyl-substituted steroids
DE2920184A1 (de) * 1979-05-17 1980-11-27 Schering Ag 16 alpha -alkylsteroide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US5952319A (en) * 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
DE19827522A1 (de) * 1998-06-22 1999-12-23 Jenapharm Gmbh 14,15-Cyclopropanosteroide der 19-Nor-Androstanreihe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
AR034194A1 (es) 2004-02-04
CA2431328A1 (en) 2002-06-20
AU2002229663A1 (en) 2002-06-24
PE20020752A1 (es) 2002-08-22
IL156208A0 (en) 2003-12-23
WO2002048169A1 (en) 2002-06-20
EP1343804A1 (en) 2003-09-17
BR0116127A (pt) 2003-11-04
JP2004520300A (ja) 2004-07-08
US20040059140A1 (en) 2004-03-25
CN1481388A (zh) 2004-03-10

Similar Documents

Publication Publication Date Title
IL183645A0 (en) Process for the preparation of drospirenone
EP2433951A3 (en) A process for the preparation of drospirenone
IL166432A0 (en) Composition containing an androgenous 11?-halogen steroid and a progestational hormone and male contraceptive based on said composition
MY101778A (en) Multiphase combined preparation and its use for oral contraception
LT1632237T (lt) Kompozicijos, apimančios drospirenoną ir etinilestradiolio bei ciklodekstrino kompeksą
HK1056181A1 (zh) 作為抗炎劑的17β-硫代羧酸酯17α-芳基羰氧基氧雄甾烷衍生物
AU2001244008A1 (en) Conductive concrete composition
PL317830A1 (en) Derivatives of a sterol used for controlling meiosis
TW200603469A (en) Male-female electrode joint
SG167670A1 (en) Aminocyclohexyl ether compounds and uses thereof
AU640396B2 (en) 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha-reductase
DE602004017151D1 (en) Gonadotropin releasing hormone analoga konjugate mit steroid hormonen
EP1042352A4 (en) ANDROGENIC STEROID COMPOUNDS AND METHOD OF MANUFACTURE AND USE THEREOF
SI1539796T1 (sl) Protivnetni ali protialergični androstanski kompleksi
MXPA03005372A (es) Androgenos 14 (15) -insaturados, 15- y/o 16-sustituidos, con perfil de actividad mixto androgenico-progestacional.
HU9902668D0 (en) Compounds with growth hormone releasing properties
YU88702A (sh) NOVI OBLICI MEZOPROGESTIN 11Гџ-[4E(HIDROKSIMINOMETIL)-FENIL]-17α-METOKSIMETIL-17Гџ-METOKSI-ESTRA-4,9-DIEN-3-ONA U ČVRSTIM FAZAMA
PL372460A1 (en) C-17 spirolactonization and 6,7 oxidation of steroids
ES2171943T3 (es) Nuevo procedimiento de isomerizacion del radical metilo en posicion 10 de derivados de eritromicina.
MXPA05006106A (es) 17.beta-(alpha-hidroxi)-esteres de androstanos como intermediarios para la preparacion de esteres androstanos 17.beta.-fluorinados.
MXPA04005788A (es) Proceso para preparacion de derivados de [1,4,5]-oxadiazepina.
PT1635843E (pt) Terapia de substituição hormonal e de depressão compreendendo dienogest
DK1196428T3 (da) 11-beta-aryl-17,17-spirothiolan-substituerede steroider
MX2024004003A (es) Proceso para preparar monohidrato de (15alfa,16alfa,17beta)-estra- 1,3,5(10)-trien-3,15,16,17-tetrol (estetrol).
HK1052012A1 (en) 16, 17-Carbocyclic condensed steroid compounds having selective estrogenic activity.